The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification of patients with ovarian cancer who are experiencing the highest benefit from bevacizumab in first-line setting based on their tumor intrinsic chemosensitivity (KELIM): GOG-0218 validation study.
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; Daiichi Sankyo Europe GmbH; ECS PROGASTRIN; GlaxoSmithKline; Immunomedics; LEK; MSD Oncology; Myriad Genetics; Novartis; Roche/Genentech; Seagen; TESARO
Research Funding - Clovis Oncology (Inst); Merck Serono (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; MSD Oncology; Roche/Genentech
 
Christopher Purdy
No Relationships to Disclose
 
Elizabeth M. Swisher
Leadership - IDEAYA Biosciences
 
Michael A. Bookman
Employment - The Permanente Medical Group
Consulting or Advisory Role - Abbvie; Aravive; AstraZeneca; Genentech/Roche; Immunogen; Merck Sharp & Dohme; Seagen
 
Gini F. Fleming
Honoraria - Curio Science; Physicans' Education Resource
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Celldex (Inst); Compugen (Inst); Corcept Therapeutics (Inst); CytomX Therapeutics (Inst); GlaxoSmithKline (Inst); Iovance Biotherapeutics (Inst); K-Group Beta (Inst); Molecular Templates (Inst); Plexxikon (Inst); Roche (Inst); Sermonix Pharmaceuticals (Inst); Syros Pharmaceuticals (Inst)
(OPTIONAL) Uncompensated Relationships - Abbvie; TTC Oncology
 
Robert L. Coleman
Employment - US Oncology
Leadership - Onxeo
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Abbvie; Abbvie/Stemcentrx; Agenus; Alkermes; AstraZeneca/MedImmune; Clovis Oncology; Genentech/Roche; Genmab; Gradalis; Immunogen; Merck; Merck; Novocure; Oncolytics; OncoMed; OncXerna Therapeutics; Regeneron; Sotio; Tesaro
Research Funding - Abbott/AbbVie; Amgen (Inst); Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Immunogen (Inst); Johnson & Johnson; Lilly (Inst); Merck; Mirati Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group
 
Leslie M. Randall
Honoraria - BluPrint Oncology; Curio Science; PER; Projects in Knowledge; Projects in Knowledge
Consulting or Advisory Role - Agenus; AstraZeneca; Clovis Oncology; Eisai; EMD Serono; Genentech/Roche; GOG Foundation; Merck; Mersana; Myriad Genetics; Novartis; Rubius Therapeutics; Seagen
Speakers' Bureau - AstraZeneca; Merck; Tesaro
Research Funding - Aivita Biomedical (Inst); Akeso Biopharma (Inst); AstraZeneca (Inst); GEICO (Inst); Genentech/Roche (Inst); Merck (Inst); On Target Laboratories (Inst); Pfizer (Inst); Tesaro (Inst)
 
Krishnansu Sujata Tewari
Honoraria - AstraZeneca; Clovis Oncology; Eisai; Genmab; Merck; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; Genmab; Merck; Roche/Genentech; Tesaro
Research Funding - Abbvie (Inst); Genentech/Roche (Inst); Merck (Inst); Morphotek (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Bradley J. Monk
Leadership - US Oncology
Honoraria - Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Bayer; Clovis Oncology; Eisai; Elevar Therapeutics; EMD Serono/Merck; Genmab/Seattle Genetics; GOG Foundation; Gradalis; ImmunoGen; Iovance Biotherapeutics; Karyopharm Therapeutics; Macrogenics; Merck; Mersana; Myriad Pharmaceuticals; Novocure; Pfizer; Puma Biotechnology; Regeneron; Roche/Genentech; Sorrento Therapeutics; TESARO/GSK; US Oncology; Vascular Biogenics
Consulting or Advisory Role - Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Bayer; Clovis Oncology; Eisai; Elevar Therapeutics; EMD Serono/Merck; Genmab/Seattle Genetics; GOG Foundation; Gradalis; Gradalis; ImmunoGen; Iovance Biotherapeutics; Karyopharm Therapeutics; Merck; Mersana; Myriad Pharmaceuticals; Novocure; Pfizer; Puma Biotechnology; Regeneron; Roche/Genentech; Sorrento Therapeutics; TESARO/GSK; US Oncology; Vascular Biogenics
Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; Merck; Roche/Genentech; TESARO/GSK
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)
 
Robert S. Mannel
Stock and Other Ownership Interests - Danaher; Edwards Lifesciences; Stryker
 
Joan L. Walker
Research Funding - Genentech; Pieces Tech (Inst); us biotest
 
Fabio Cappuccini
Honoraria - AstraZeneca; GlaxoSmithKline
Speakers' Bureau - AstraZeneca; GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - sponsored programs
 
Larry J. Copeland
Consulting or Advisory Role - Celsion; Corcept Therapeutics; Elevar Therapeutics; GlaxoSmithKline; Myriad Genetics; Rubius Therapeutics; Sorrento Therapeutics; Tarveda Therapeutics; Tarveda Therapeutics; Toray Industries
 
Mahvish Muzaffar
No Relationships to Disclose
 
David Gardner Mutch
Consulting or Advisory Role - lilly
 
Andrea Elisabeth Wahner Hendrickson
Consulting or Advisory Role - Oxcia
Research Funding - Amgen (Inst); ProLynx (Inst)
 
Lainie P. Martin
Consulting or Advisory Role - Elucida Oncology; GlaxoSmithKline; Sutro Biopharma
Research Funding - Agenus (Inst); AstraZeneca (Inst); Immunogen (Inst); Sutro bioPharma (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Olivier Colomban
No Relationships to Disclose
 
Robert Allen Burger
Employment - Genentech/Roche; Mersana
Stock and Other Ownership Interests - Genentech/Roche; Mersana
Consulting or Advisory Role - Myriad Genetics